7 September 2002

Excess Pricing in the Napp Chapter II Case – how much is too much?

RBB Brief 5 discusses the controversial issue of excess pricing as an abuse in the context of the UK Competition Act case involving Napp Pharmaceuticals

Downloadpdf (87 KB)

Our experience and expertise means our clients have the best chance of success before competition authorities and courts.

We have unrivalled experience across the full range of issues presented by competition law and related associated litigation.


All Articles
  • Article05/05/2023
    RBB response to the EC’s updated Article 102 TFEU Guidance and Policy Brief
  • Brief 6601/11/2022
    Seeing vertical mergers through a different lens? Implications from EssilorLuxottica / GrandVision